The success of any gene-modified therapy begins with the correct plasmid. At Minaris Advanced Therapies, our plasmid engineering services lay the foundation for long-term success by designing and optimizing plasmids for superior transgene expression, expression control, yield and safety.
We collaborate with your R&D team at the earliest stages to create constructs that are fit-for-purpose and scalable, ensuring your therapeutic candidate performs as intended from discovery through IND-enabling studies. We facilitate a smooth transition from research-grade plasmids to scalable GMP manufacturing through our strategic partnerships with specialized plasmid manufacturers.
